Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate

被引:31
|
作者
Innocenti, A [1 ]
Vullo, D [1 ]
Scozzafava, A [1 ]
Supuran, CT [1 ]
机构
[1] Univ Florence, Chim Bioorgan Lab, I-50019 Sesto Fiorentino, Firenze, Italy
关键词
D O I
10.1016/j.bmcl.2004.11.056
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The inhibition of five human carbonic anhydrase (hCA, EC 4.2.1.1) isozymes; the cytosolic hCA I and II, the membrane-bound hCA IV. the mitochondrial hCA V, and the tumor-associated, transmembrane hCA IX, with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate; such as chlorate, perchlorate, bromate, iodate, periodate, silicate, bismuthate, vanadate, molybdate, and wolframate is reported. Apparently, the geometry of the inhibitor (tetrahedral or trigonal) does not influence its binding to the Zn(II) ion of the enzyme active site, but the nature of the central element is the most important factor influencing potency. Isozymes hCA I and II are best inhibited by chlorate, perchlorate, and silicate, together with the anions structurally related to sulfate, sulfamate, and sulfamidate, but sulfate itself is a weak inhibitor (inhibition constant of 74 mM against hCA I and 183 mM against hCA II). Molybdate is a very weak hCA I inhibitor (K-I of 914 mM) but it interacts with hCA II (K-I of 27.5 mM). Isozyme IV is well inhibited by sulfate (K-I of 9 mM), sulfamate, and sulfamidate (in the low micromolar range), but not by perchlorate (KI of 767 mM). The mitochondrial isozyme V has the lowest affinity for sulfate (KI of 680 mM) and carbonate (K-I of 95 mM) among all the investigated isozymes, suggesting on one hand its possible participation in metabolon(s) with sulfate anion exchanger(s), and on the other hand an evolutionary adaptation to working at higher pH values (around 8.5 in mitochondria) where rather high amounts of carbonate in equilibrium with bicarbonate may be present. Metasilicate, isosteric to carbonate, is also about a 10 times weaker inhibitor of this isozyme as compared to other CAs investigated here (K-I of 28.2 mM). Surprisingly, the tumor-associated isozyme IX is resistant to sulfate inhibition (K-I of 154 mM) but has affinity in the low micromolar range for carbonate, sulfamate, and sulfamidate (K-I in the range of 8.6-9.6 muM). This constitutes another proof that this isozyme best works at acidic pH values present in tumors, being inhibited substantially at higher pH values when more carbonate may be present. Bromate and chlorate are quite weak CA IX inhibitors (KI s of 147-274 mM). (C) 2004 Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码:567 / 571
页数:5
相关论文
共 50 条
  • [21] Inhibition of carbonic anhydrase isozymes I, II and IX with benzenesulfonamides containing an organometallic moiety
    Salmon, Adam J.
    Williams, Michael L.
    Innocenti, Alessio
    Vullo, Damela
    Supuran, Claudiu T.
    Poulsen, Sally-Ann
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) : 5032 - 5035
  • [22] Carbonic anhydrase inhibitors: Inhibition of cytosolic isozymes I and II with sulfamide derivatives
    Casini, A
    Winum, JY
    Montero, JL
    Scozzafava, A
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (05) : 837 - 840
  • [23] Carbonic anhydrase inhibitors:: Synthesis and inhibition of cytosolic membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties
    Winum, JY
    Dogné, JM
    Casini, A
    de Leval, X
    Montero, JL
    Scozzafava, A
    Vullo, D
    Innocenti, A
    Supuran, CT
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 2121 - 2125
  • [24] Carbonic anhydrase inhibitors. Selective inhibition of human tumor-associated isozymes IX and XII and cytosolic isozymes I and II with some substituted-2-mercapto-benzenesulfonamides
    Saczewski, Franciszek
    Innocenti, Alessio
    Brzozowski, Zdzislaw
    Slawinski, Jaroslaw
    Pomarnacka, Elzbieta
    Kornicka, Anita
    Scozzafava, Andrea
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2006, 21 (05) : 563 - 568
  • [25] Carbonic anhydrase inhibitors. Inhibition of the cytosolic human isozymes I and II, and the transmembrane, tumor-associated isozymes IX and XII with substituted aromatic sulfonamides activatable in hypoxic tumors
    Saczewski, Franciszek
    Slawinski, Jaroslaw
    Kornicka, Anita
    Brzozowski, Zdzislaw
    Pomarnacka, Elzbieta
    Innocenti, Alessio
    Scozzafava, Andrea
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (18) : 4846 - 4851
  • [26] Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails
    Winum, Jean-Yves
    Thiry, Anne
    El Cheikh, Khaled
    Dogne, Jean-Michel
    Montero, Jean-Louis
    Vullo, Daniela
    Scozzafava, Andrea
    Masereel, Bernard
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (10) : 2685 - 2691
  • [27] Carbonic anhydrase inhibitors: Inhibition of isozymes I, II and IV with heterocyclic mercaptans, sulfenamides, sulfonamides and their metal complexes
    Supuran, CT
    Scozzafava, A
    Saramet, I
    Banciu, MD
    JOURNAL OF ENZYME INHIBITION, 1998, 13 (03): : 177 - 194
  • [28] Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the cytosolic isoforms I and II
    Carta, Fabrizio
    Maresca, Alfonso
    Scozzafava, Andrea
    Vullo, Daniela
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (20) : 7093 - 7099
  • [29] Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes
    Puccetti, L
    Fasolis, G
    Vullo, D
    Chohan, ZH
    Scozzafava, A
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (12) : 3096 - 3101
  • [30] Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors
    Winum, JY
    Vullo, D
    Casini, A
    Montero, JL
    Scozzafava, A
    Supuran, CT
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (11) : 2197 - 2204